EDGAR Filing Documents for 0001104659-13-050885

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001104659-13-050885

Filing Date

2013-06-24

Accepted

2013-06-24 07:08:36

Documents

Period of Report

2013-06-21

Document Format Files

Seq	Description	Document	Type	Size
1	4	a4.html	4
1	4	a4.xml	4	3060
	Complete submission text file	0001104659-13-050885.txt		4659

Mailing Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170

Business Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170 212-297-0010

SYNERGY PHARMACEUTICALS, INC. (Issuer) CIK: 0001347613 (see all company filings)

IRS No.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CALLISTO PHARMACEUTICALS, INC. 420 LEXINGTON AVENUE, SUITE 1609 NEW YORK NY 10170

Business Address

Type: 4 | Act: 34 | File No.: 001-35268 | Film No.: 13928433